Premium
Marine toxins and the cytoskeleton: pectenotoxins, unusual macrolides that disrupt actin
Author(s) -
Espiña Begoña,
Rubiolo Juan A.
Publication year - 2008
Publication title -
the febs journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.981
H-Index - 204
eISSN - 1742-4658
pISSN - 1742-464X
DOI - 10.1111/j.1742-4658.2008.06714.x
Subject(s) - cytoskeleton , actin , actin cytoskeleton , biology , toxicity , microbiology and biotechnology , chemistry , biochemistry , cell , organic chemistry
In recent years, many natural macrolactones have been found that display toxicity against the actin cytoskeleton. Pectenotoxins are macrolactones produced by species of the dinoflagellate genus Dinophysis . They were initially classified within the diarrheic shellfish poisoning group of toxins, because of their co‐occurrence and biological origin, but mice toxicity assays demonstrated that pectenotoxins do not induce diarrheic symptoms. Intraperitoneal injection of pectenotoxins into mice produces high hepatotoxicity as the principal symptom, so the liver seems to be their target organ. Up to now, 15 pectenotoxin analogs have been discovered, with different toxicological potencies that are related to their structures. Now, it is generally accepted that the actin cytoskeleton is the principal molecular target of pectenotoxins. Although recent studies have demonstrated that pectenotoxins induce actin filament disruption by a capping effect, other kinds of activity, such as sequestration of actin, cannot be ruled out. All of the active analogs tested triggered disruption of the actin cytoskeleton and displayed potencies that correlated with their toxicity in mice. Moreover, pectenotoxins induce apoptosis to a higher degree in tumor cells than in normal cells of the same tissue. This fact opens the prospect of studying new chemotherapy agents and actin cytoskeleton dynamics with potential clinical applications.